(Q42642978)

4 November 2017

title

Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals (English)

1 reference

4 November 2017

1 reference

1 reference

H Hollander

1

1 reference

4 November 2017

A R Lifson

2

1 reference

4 November 2017

M Maha

3

1 reference

4 November 2017

R Blum

4

1 reference

4 November 2017

G W Rutherford

5

1 reference

4 November 2017

S Nusinoff-Lehrman

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

American Journal of Medicine

4 November 2017

published in

1 reference

4 November 2017

volume

87

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

628-632

1 reference

Epidemiology of HIV infection and AIDS in the United States

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Human immunodeficiency virus-associated myopathy: analysis of 11 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Subacute Structural Myopathy Associated With Human Immunodeficiency Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980394-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(89)80394-8

1 reference

4 November 2017

1 reference